These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1083981)

  • 1. Antibody-producing cells: virus-induced alteration of response to antigen.
    Riley V; Braun W; Ishizuka M; Spackman D
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1707-11. PubMed ID: 1083981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an acute viral infection by a silent virus on the humoral immune responses.
    Isakov N; Feldman M; Segal S
    Adv Exp Med Biol; 1982; 149():455-60. PubMed ID: 6983226
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical influence of an enzyme-elevating virus upon long-term remissions of mouse leukemia following asparaginase therapy.
    Riley V; Spackman DH; Fitzmaurice MA
    Recent Results Cancer Res; 1970; 33():81-101. PubMed ID: 4949171
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the LDH-elevating virus in leukemia therapy by asparaginase.
    Riley V
    Nature; 1968 Dec; 220(5173):1245-6. PubMed ID: 5725988
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus.
    Isakov N; Feldman M; Segal S
    J Immunol; 1982 Feb; 128(2):969-75. PubMed ID: 7198665
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistence and other characteristics of the lactate dehydrogenase-elevating virus (LDH-virus).
    Riley V
    Prog Med Virol; 1974; 18(0):198-213. PubMed ID: 4608417
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphopenia and impaired immunological activities of splenocytes during the immune response to cholera enterotoxin.
    Kateley JR; Holderbach J; Friedman H
    Immunology; 1978 Oct; 35(4):627-36. PubMed ID: 361547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a benign virus upon mouse leukemia during asparaginase therapy.
    Riley V
    Pathol Biol (Paris); 1970; 18(15):757-64. PubMed ID: 4917552
    [No Abstract]   [Full Text] [Related]  

  • 10. Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation.
    Bradley DS; Broen JJ; Cafruny WA
    Viral Immunol; 1991; 4(1):59-70. PubMed ID: 1905935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacologic properties of L-asparaginase bonded to dacron vascular prostheses.
    Cooney DA; Weetall HH; Long E
    Biochem Pharmacol; 1975 Feb; 24(4):503-15. PubMed ID: 234240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic specificity of local inhibitory intercellular interactions].
    Grigor'eva OS; Korukova AA; Gurvich AE
    Biull Eksp Biol Med; 1978 Jun; 85(6):696-8. PubMed ID: 566593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
    Cerny J; Waner EB
    J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A2 inhibits murine in vitro antibody synthesis.
    Daniels CA; Marbrook J
    J Immunol; 1981 May; 126(5):1737-41. PubMed ID: 6971313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of Alexan on the number of plaque-forming cells collected from the spleen of C3H mice with Gardner's lymphosarcoma or infected with LDH viruses].
    Motycka K; Herzog P; Chudomel V; Bostík J; Jandová A; Pezlarová J; Stĕpánová I
    Sb Lek; 1984 Sep; 86(8-9):251-8. PubMed ID: 6548832
    [No Abstract]   [Full Text] [Related]  

  • 16. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes.
    Isaak DD; Price JA; Reinisch CL; Cerny J
    J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation of antigenic markers on B cells and on antibody-forming cells.
    McKenzie IF; Elliott BE; Haskill JS
    Isr J Med Sci; 1975 Dec; 11(12):1278-84. PubMed ID: 56321
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the functional activity of T- and B-lymphocytes in experimental infection due to different strains of the influenza virus].
    Savtsova ZD; Iudina OIu
    Vopr Virusol; 1982; (1):20-3. PubMed ID: 6978571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sheep erythrocyte and bluetongue virus antibody responses of spleen cell cultures from mice.
    Oellermann RA; Carter P
    Onderstepoort J Vet Res; 1977 Sep; 44(3):139-42. PubMed ID: 208037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of interaction between T and B lymphocytes in the in vitro response to sheep erythrocytes. Non-specific collaboration across a dialysis membrane.
    Adams PB
    Immunology; 1975 Feb; 28(2):253-69. PubMed ID: 1079016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.